Publication: Healthcare-associated Gram-negative bloodstream infections: Antibiotic resistance and predictors of mortality
dc.contributor.buuauthor | Yılmaz, Emel | |
dc.contributor.buuauthor | Akalın, Halis | |
dc.contributor.department | Tıp Fakültesi | |
dc.contributor.department | Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Ana Bilim Dalı | |
dc.contributor.orcid | 0000-0002-3894-1231 | |
dc.contributor.researcherid | AAU-8952-2020 | |
dc.contributor.scopusid | 22037135100 | |
dc.contributor.scopusid | 57207553671 | |
dc.date.accessioned | 2022-10-27T11:02:40Z | |
dc.date.available | 2022-10-27T11:02:40Z | |
dc.date.issued | 2016-12 | |
dc.description | Çalışmada 28 yazar bulunmaktadır. Bu yazarlardan sadece Bursa Uludağ Üniversitesi mensubu yazarların girişleri yapılmıştır. | |
dc.description.abstract | This article describes the prevalence of antibiotic resistance and predictors of mortality for healthcare-associated (HA) Gram-negative bloodstream infections (GN-BSI). In total, 831 cases of HA GN-BSI from 17 intensive care units in different centres in Turkey were included; the all-cause mortality rate was 44%. Carbapenem resistance in Klebsiella pneumoniae was 38%, and the colistin resistance rate was 6%. Multi-variate analysis showed that age > 70 years [odds ratio (OR) 2, 95% confidence interval (CI) 1.22-3.51], central venous catheter use (OR 2.1, 95% CI 1.09-4.07), ventilator- associated pneumonia (OR 1.9, 95% CI 1.1-3.16), carbapenem resistance (OR 1.8, 95% CI 1.11-2.95) and APACHE II score (OR 1.1, 95% CI 1.07-1.13) were significantly associated with mortality. | |
dc.identifier.citation | Ergönül, O. vd. (2016). "Healthcare-associated Gram-negative bloodstream infections: Antibiotic resistance and predictors of mortality". Journal of Hospital Infection, 94(4), 381-385. | |
dc.identifier.endpage | 385 | |
dc.identifier.issn | 0195-6701 | |
dc.identifier.issn | 1532-2939 | |
dc.identifier.issue | 4 | |
dc.identifier.pubmed | 27717604 | |
dc.identifier.scopus | 2-s2.0-84996899090 | |
dc.identifier.startpage | 381 | |
dc.identifier.uri | https://doi.org/10.1016/j.jhin.2016.08.012 | |
dc.identifier.uri | https://www.sciencedirect.com/science/article/pii/S0195670116303280 | |
dc.identifier.uri | http://hdl.handle.net/11452/29241 | |
dc.identifier.volume | 94 | |
dc.identifier.wos | 000389233700014 | |
dc.indexed.wos | SCIE | |
dc.language.iso | en | |
dc.publisher | W B Saunders | |
dc.relation.collaboration | Yurt içi | |
dc.relation.collaboration | Sanayi | |
dc.relation.journal | Journal of Hospital Infection | |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.subject | Public, environmental & occupational health | |
dc.subject | lthInfectious diseases | |
dc.subject | Bloodstream | |
dc.subject | Gram-negative | |
dc.subject | Healthcare | |
dc.subject | Klebsiella-pneumoniae | |
dc.subject | Outcomes | |
dc.subject | Impactenterobacteriaceae | |
dc.subject | Epidemiology | |
dc.subject | Surveillance | |
dc.subject | Bacteremia | |
dc.subject | Program | |
dc.subject.emtree | Aminoglycoside antibiotic agent | |
dc.subject.emtree | Antibiotic agent | |
dc.subject.emtree | Carbapenem | |
dc.subject.emtree | Cephalosporin | |
dc.subject.emtree | Colistin | |
dc.subject.emtree | Piperacillin plus tazobactam | |
dc.subject.emtree | Quinoline derived antiinfective agent | |
dc.subject.emtree | Acinetobacter baumannii | |
dc.subject.emtree | Adult | |
dc.subject.emtree | APACHE | |
dc.subject.emtree | Article | |
dc.subject.emtree | Bloodstream infection | |
dc.subject.emtree | Cause of death | |
dc.subject.emtree | Central venous catheter | |
dc.subject.emtree | Controlled clinical trial | |
dc.subject.emtree | Controlled study | |
dc.subject.emtree | Enterobacter cloacae | |
dc.subject.emtree | Escherichia coli | |
dc.subject.emtree | Female | |
dc.subject.emtree | Gram negative infection | |
dc.subject.emtree | Healthcare associated infection | |
dc.subject.emtree | Human | |
dc.subject.emtree | Intensive care unit | |
dc.subject.emtree | Klebsiella pneumoniae | |
dc.subject.emtree | Major clinical study | |
dc.subject.emtree | Male | |
dc.subject.emtree | Mortality | |
dc.subject.emtree | Mortality rate | |
dc.subject.emtree | Multicenter study | |
dc.subject.emtree | Nonhuman | |
dc.subject.emtree | Pseudomonas aeruginosa | |
dc.subject.emtree | Retrospective study | |
dc.subject.emtree | Turkey (republic) | |
dc.subject.emtree | Ventilator associated pneumonia | |
dc.subject.emtree | Aged | |
dc.subject.emtree | Antibiotic resistance | |
dc.subject.emtree | Bacteremia | |
dc.subject.emtree | Classification | |
dc.subject.emtree | Clinical trial | |
dc.subject.emtree | Cross infection | |
dc.subject.emtree | Drug effects | |
dc.subject.emtree | Gram negative bacterium | |
dc.subject.emtree | Gram-negative bacterial infections | |
dc.subject.emtree | Isolation and purification | |
dc.subject.emtree | Microbiology | |
dc.subject.emtree | Middle aged | |
dc.subject.emtree | Prevalence | |
dc.subject.emtree | Prognosis | |
dc.subject.emtree | Risk factor | |
dc.subject.emtree | Survival analysis | |
dc.subject.emtree | Turkey | |
dc.subject.mesh | Adult | |
dc.subject.mesh | Aged | |
dc.subject.mesh | Bacteremia | |
dc.subject.mesh | Cross infection | |
dc.subject.mesh | Drug resistance, bacterial | |
dc.subject.mesh | Female | |
dc.subject.mesh | Gram-negative bacteria | |
dc.subject.mesh | Gram-negative bacterial infections | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Intensive care units | |
dc.subject.mesh | Male | |
dc.subject.mesh | Middle aged | |
dc.subject.mesh | Prevalence | |
dc.subject.mesh | Prognosis | |
dc.subject.mesh | Retrospective studies | |
dc.subject.mesh | Risk factors | |
dc.subject.mesh | Survival analysis | |
dc.subject.mesh | Turkey | |
dc.subject.scopus | Beta-Lactamases; Carbapenem-Resistant Enterobacteriaceae; Klebsiella Pneumoniae | |
dc.subject.wos | Public, environmental & occupational health | |
dc.subject.wos | Infectious diseases | |
dc.title | Healthcare-associated Gram-negative bloodstream infections: Antibiotic resistance and predictors of mortality | |
dc.type | Article | |
dc.wos.quartile | Q2 | |
dspace.entity.type | Publication | |
local.contributor.department | Tıp Fakültesi/Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji Ana Bilim Dalı | |
local.indexed.at | Scopus | |
local.indexed.at | WOS |
Files
License bundle
1 - 1 of 1
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed upon to submission
- Description: